BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16815552)

  • 1. Citrobacter infections in a tertiary care hospital in Northern India.
    Mohanty S; Singhal R; Sood S; Dhawan B; Kapil A; Das BK
    J Infect; 2007 Jan; 54(1):58-64. PubMed ID: 16815552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic sensitivity pattern of Citrobacter isolated from various clinical specimens in a tertiary care hospital.
    Shetty J; Kotigadde S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):666-8. PubMed ID: 17883179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteraemia caused by non-freundii, non-koseri Citrobacter species in Taiwan.
    Lai CC; Tan CK; Lin SH; Liu WL; Liao CH; Huang YT; Hsueh PR
    J Hosp Infect; 2010 Dec; 76(4):332-5. PubMed ID: 20708303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
    Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
    Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endophthalmitis caused by Citrobacter species.
    Chen KJ; Sun MH; Hwang YS; Chen TL; Lai CC; Chen YP
    Ocul Immunol Inflamm; 2008; 16(4):147-53. PubMed ID: 18716949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
    Khorasani G; Salehifar E; Eslami G
    Burns; 2008 Nov; 34(7):947-52. PubMed ID: 18378087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan.
    Liu CP; Weng LC; Tseng HK; Wang NY; Lee CM
    J Infect; 2007 Oct; 55(4):363-8. PubMed ID: 17572502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species prevalence and antimicrobial susceptibility of enterococci isolated in a tertiary care hospital of North India.
    Mohanty S; Jose S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):962-5. PubMed ID: 16295552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunovic-Kamberovic S
    J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
    Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
    Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
    Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
    Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-microbial resistance profile of Citrobacter species in a tertiary care hospital of Southern India.
    Metri BC; Jyothi P; Peerapur BV
    Indian J Med Sci; 2011 Oct; 65(10):429-35. PubMed ID: 23511043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia.
    Tessema B; Kassu A; Mulu A; Yismaw G
    Ethiop Med J; 2007 Jan; 45(1):61-7. PubMed ID: 17642159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antimicrobial susceptibility of Citrobacter freundii isolates in two different time periods.
    Wang JT; Chang SC; Chen YC; Luh KT
    J Microbiol Immunol Infect; 2000 Dec; 33(4):258-62. PubMed ID: 11269372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of KPC-2-producing Citrobacter freundii isolates in Spain.
    Gómez-Gil MR; Paño-Pardo JR; Romero-Gómez MP; Gasior M; Lorenzo M; Quiles I; Mingorance J
    J Antimicrob Chemother; 2010 Dec; 65(12):2695-7. PubMed ID: 20851814
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.
    Drelichman V; Band JD
    Arch Intern Med; 1985 Oct; 145(10):1808-10. PubMed ID: 3899035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
    Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP
    J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.
    Gaibani P; Ambretti S; Farruggia P; Bua G; Berlingeri A; Tamburini MV; Cordovana M; Guerra L; Mazzetti M; Roncarati G; Tenace C; Moro ML; Gagliotti C; Landini MP; Sambri V
    Int J Infect Dis; 2013 Sep; 17(9):e714-7. PubMed ID: 23528638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.